DataKnowledgeCloudtrainingcoordination

COL Q12888-1 GLY 000517 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

TP53B HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Compound:

N-ACETYL-beta-D-GLUCOSAMINE

Compound (Entity type)

Collection:

human proteoform glycosylation sites oglcnac mcw.csv

File (Entity type)

Description:Information for protein Q12888-1 in the context of file GLY_000517

Creation Time:2026-03-02 19:57:25.000000

Results found

Linked to

	Label	Description
	TP53B HUMAN Protein (Entity type)	TP53-binding protein 1
	q12888-1 864thr 864thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q12888-1 1644ser 1644ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q12888-1 1631ser 1631ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q12888-1 1094ser 1094ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q12888-1 1643ser 1643ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q12888-1 1642ser 1642ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q12888-1 659ser 659ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q12888-1 1634ser 1634ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q12888-1 1640thr 1640thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

Protein

TP53B HUMAN

Protein (Entity type)

TP53-binding protein 1

Post Translational Modification

q12888-1 864thr 864thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q12888-1 1644ser 1644ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q12888-1 1631ser 1631ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q12888-1 1094ser 1094ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q12888-1 1643ser 1643ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q12888-1 1642ser 1642ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q12888-1 659ser 659ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q12888-1 1634ser 1634ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q12888-1 1640thr 1640thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.